Submit manuscript at http://omicsonline.org/submitmanuscript-pharmacogenomics-pharmacoproteomics-open-access.php or send as an e-mail attachment to the Editorial Office at email@example.com
Impact Factor: 1.69*
The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.
The Pharmacogenomics & Pharmacoproteomics Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacogenomics & Pharmacoproteomics journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacogenomics and Pharmacoproteomics Open Access Journals are freely accessible to everyone immediately after publication.
Pharmacogenomics is part of a field called personalized medicine that aims to customize health care, with decisions and treatments tailored to each individual patient in every way possible.
Genetic variation influences the response of an individual to drug treatments. cancer, tumours may have specific disease-defining mutations, but a patient's germline genetic variation will also affect drug response. Cancer pharmacogenomics focus on the study of this genetic variation.
Pharmacogenetic approaches are widely expected to bring about a revolution in future medicine.
Pharmacogenomics database is a resource for identifying all genetic variants that have been shown to affect drug response in patients.
Majority of pharmaceutical &medical agencies nowadays are actively involved in finding of genetic varioation and their affect on drug response to individual patient.
There are several applications in the pharmaceutical industry for analysis in the area of pharmacogenetics / pharmacogenomics, like transcriptome analysis, or specific analysis of genes which are important for drug response and drug effect.
The study of the genetic basis for variation in drug response has provided important insights into a personalized approach to prescribing and dosing medications for patient care.
Pharmacoproteomics is the use of proteomic technologies in drug discovery and development. Along with pharmacogenomics and pharmacogenetics, pharmacoproteomics will play an important role in the development of personalized medicines.
Proteomics is an alternate methodology where all blood proteins modulated by disease or drug are used to resolve pharmacodynamic questions without the time, cost, and risk of developing an immunoassay.
Clinical pharmacogenomics quantitatively characterize the preliminary marker classifier performance like sensitivity, specificity, predictive values, reclassification, and explore the prognostic and predictive attributes of the marker.
The rapid development of techniques in the area of genome analysis has facilitated identification of new pharmacogenomic biomarkers that can provide predictive tools for improved drug response and fewer adverse drug reactions
Gene polymorphism is the simultaneous occurrence in the same locality of two or more discontinuous forms in such proportions that the rarest of them cannot be maintained just by recurrent mutation or immigration.
Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself.
Translational medicine is a biomedical and public health research that plays main role to improve the health of individuals and the community by translating findings into diagnostic tools, medicines, procedures, policies and education.
Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease.
Toxicogenomics is a branch of science that deals with the collection, interpretation, and storage of information about gene and protein activity within particular cell or tissue of an organism in response to toxic substances.
Immune system begins to develop in the embryo and it localized In the several parts of the body. Immune cells develop in the primary organs like bone marrow and thymus. Immune responses occur in the secondary organs like spleen etc. Immune dosorders are nothing but a disease in which the body produces antibodies that attack its own tissues, leading to the deterioration and in some cases to the destruction of such tissue.
Metabolic disorder is a disorder or defect of metabolism, a physical condition in which there is a disturbance of normal functioning.
It is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
It is a medical model that proposes the customization of healthcare - with medical decisions, practices, and/or products being tailored to the individual patient.
The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination
A drug dose is the specific amount of medication to be taken at a given time. The dose and time to take the medication are written on a doctor’s prescription or recommended on the label of an over-the-counter medication
Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug
OMICS International group is delighted to invite you to attend the 3rd International Conference on Genomics and Pharmacogenomics during september 21-23, 2015 San Antonio, USA.
*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If X is the total number of articles published in 2012 and 2013, and Y is the number of times these articles were cited in indexed journals during 2014 than, impact factor = X/Y